1.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-550474
RESUMO
24 patients with chronic hepatitis B were treated with interleukin-2 activated human peripheral blood lymphocytes (IAPBL). 23 patients served as control. The results showed that HBeAg disappeared in 54.2% of IAPBL group, in comparison with 17.4% of the controls (P